BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2033971)

  • 1. [Mortality in patients with chronic renal insufficiency undergoing hemodialysis. Hyperlipemia as coadjuvant factor].
    Joven J; Vilella E; Brunzell JD
    Med Clin (Barc); 1991 Jan; 96(3):110-3. PubMed ID: 2033971
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflection point of ascending aortic waveform is a predictive factor for all-cause and cardiovascular mortality in patients with chronic renal failure on hemodialysis.
    Ueda H; Hayashi T; Tsumura K; Yoshimaru K; Nakayama Y; Yoshikawa J
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1151-5. PubMed ID: 15607622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of peritoneal dialysis in the treatment of terminal chronic renal insufficiency. Survival of patients and method].
    Ryckelynck JP; Hurault de Ligny B; Levaltier B; Cardineau E; Le Goff C; Batho JM
    Nephrologie; 1995; 16(1):85-92. PubMed ID: 7700425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of uremic hyperlipemia and disturbances of glucose tolerance under chronic intermittent hemodialysis treatment].
    Hübner W; Diemer A; Freiberg J
    Med Welt; 1972 Oct; 23(41):1415-7. PubMed ID: 4648587
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular factors influencing survival in dialysis patients.
    Alpert MA
    Adv Perit Dial; 1996; 12():110-9. PubMed ID: 8865884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison and survival of patients receiving hemodialysis and peritoneal dialysis in a single center.
    Uchida K; Shoda J; Sugahara S; Ikeda N; Kobayashi K; Kanno Y; Okada H; Nakamoto H; Uchida Y; Suzuki H
    Adv Perit Dial; 2007; 23():144-9. PubMed ID: 17886622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic renal insufficiency and hyperlipemia].
    Rocha PP; Lazera ES; Sampaio JC; Amancio A
    Arq Bras Cardiol; 1979 Apr; 32(4):247-9. PubMed ID: 508107
    [No Abstract]   [Full Text] [Related]  

  • 8. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac surgery in patients on chronic hemodialysis: short and long-term survival.
    Kogan A; Medalion B; Kornowski R; Raanani E; Sharoni E; Stamler A; Sahar G; Snir E; Porat E
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):123-7. PubMed ID: 18365968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients.
    Lezaic V; Stosovic M; Marinkovic J; Rangelov V; Djukanovic L
    Ren Fail; 2008; 30(1):81-7. PubMed ID: 18197548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival on chronic dialysis: 10 years' experience of a single Colombian center.
    Enríquez J; Bastidas M; Mosquera M; Ceballos O; Bastidas B; Argote E; Salazar J; Delgado M
    Adv Perit Dial; 2005; 21():164-7. PubMed ID: 16686311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodialysis using high flux membranes improves lipid profiles.
    Blankestijn PJ
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S48-51. PubMed ID: 7923984
    [No Abstract]   [Full Text] [Related]  

  • 14. Open heart surgery in patients with end-stage renal failure: fifteen-year experience.
    Bahar I; Akgul A; Demirbag AE; Altinay L; Thompson LO; Boran M; Ozatik MA; Birincioglu L
    J Card Surg; 2009; 24(1):24-9. PubMed ID: 18778299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atherosclerosis and hemodialysis].
    Kessler M
    Nephrologie; 2000; 21(7):349-50. PubMed ID: 11200608
    [No Abstract]   [Full Text] [Related]  

  • 16. Do cardiac troponins provide prognostic insight in hemodialysis patients?
    Choy JB; Armstrong PW; Ulan RA; Campbell PM; Gourishankar S; Prosser CI; Tymchak WJ
    Can J Cardiol; 2003 Jul; 19(8):907-11. PubMed ID: 12876611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
    Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 3):I-IV, S1-91. PubMed ID: 12671933
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients.
    Kaizu Y; Tsunega Y; Yoneyama T; Sakao T; Hibi I; Miyaji K; Kumagai H
    Clin Nephrol; 1998 Jul; 50(1):44-50. PubMed ID: 9710346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate?
    O'Shea S; Duffull S; Johnson DW
    Semin Dial; 2009; 22(3):225-30. PubMed ID: 19386073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.